Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, B. A.
Right arrow Articles by Buse, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, B. A.
Right arrow Articles by Buse, M. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 6 981-991, Copyright © 2000 by American Diabetes Association


ARTICLES

High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes

BA Nelson, KA Robinson and MG Buse
Department of Medicine, Medical University of South Carolina, Charleston 29425, USA.

Sustained hyperglycemia induces insulin resistance, but the mechanism is still incompletely understood. Glucosamine (GlcN) has been extensively used to model the role of the hexosamine synthesis pathway (HSP) in glucose-induced insulin resistance. 3T3-L1 adipocytes were preincubated for 18 h in media +/- 0.6 nmol/l insulin containing either low glucose (5 mmol/l), low glucose plus GlcN (0.1-2.5 mmol/l), or high glucose (25 mmol/l). Basal and acute insulin-stimulated (100 nmol/l) glucose transport was measured after re-equilibration in serum and insulin-free media. Preincubation with high glucose or GlcN (1-2.5 mmol/l) inhibited basal and acute insulin-stimulated glucose transport only if insulin was present during preincubation. However, only preincubation with GlcN plus insulin inhibited insulin-stimulated GLUT4 translocation. GLUT4 and GLUT1 protein expression were not affected. GlcN (2.5 mmol/l) increased cellular UDP-N-acetylhexosamines (UDP-HexNAc) by 400 and 900% without or with insulin, respectively. High glucose plus insulin increased UDP-HexNAc by 30%. GlcN depleted UDP-hexoses, whereas high glucose plus insulin increased them. Preincubation with 0.5 mmol/l GlcN plus insulin maximally increased UDP-HexNAc without affecting insulin-stimulated or basal glucose transport. GlcN plus insulin (but not high glucose plus insulin) caused marked GlcN dose-dependent accumulation of GlcN-6-phosphate, which correlated with insulin resistance of glucose transport (r = 0.935). GlcN plus insulin (but not high glucose plus insulin) decreased ATP (10-30%) and UTP (>50%). GTP was not measured, but GDP increased. Neither high glucose plus insulin nor GlcN plus insulin prevented acute insulin stimulation (approximately 20-fold) of insulin receptor substrate 1-associated phosphatidylinositol (PI)-3 kinase. We have come to the following conclusions. 1) Chronic exposure to high glucose or GlcN in the presence of low insulin caused insulin resistance of glucose transport by different mechanisms. 2) GlcN inhibited GLUT4 translocation, whereas high glucose impaired GLUT4 "intrinsic activity" or membrane intercalation. 3) Both agents may act distally to PI-3 kinase. 4) GlcN has metabolic effects not shared by high glucose. GlcN may not model HSP appropriately, at least in 3T3-L1 adipocytes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Fu, L. Luo, N. Luo, X. Zhu, and W. T. Garvey
NR4A Orphan Nuclear Receptors Modulate Insulin Action and the Glucose Transport System: POTENTIAL ROLE IN INSULIN RESISTANCE
J. Biol. Chem., October 26, 2007; 282(43): 31525 - 31533.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Luo, G. J. Parker, R. C. Cooksey, Y. Soesanto, M. Evans, D. Jones, and D. A. McClain
Chronic Hexosamine Flux Stimulates Fatty Acid Oxidation by Activating AMP-activated Protein Kinase in Adipocytes
J. Biol. Chem., March 9, 2007; 282(10): 7172 - 7180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. A. Robinson, L. E. Ball, and M. G. Buse
Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E884 - E890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Z. Yacoub Wasef, K. A. Robinson, M. N. Berkaw, and M. G. Buse
Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1274 - E1280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. M. McCarthy, K. O. Spisak, J. T. Brozinick, and J. S. Elmendorf
Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C860 - C868.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. L. Sutton-McDowall, M. Mitchell, P. Cetica, G. Dalvit, M. Pantaleon, M. Lane, R. B. Gilchrist, and J. G. Thompson
Glucosamine Supplementation During In Vitro Maturation Inhibits Subsequent Embryo Development: Possible Role of the Hexosamine Pathway as a Regulator of Developmental Competence
Biol Reprod, May 1, 2006; 74(5): 881 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse
Hexosamines, insulin resistance, and the complications of diabetes: current status
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
D. C. Love and J. A. Hanover
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Sci. Signal., November 29, 2005; 2005(312): re13 - re13.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Fu, N. Luo, R. L. Klein, and W. T. Garvey
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation
J. Lipid Res., July 1, 2005; 46(7): 1369 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. A. McClain, M. Hazel, G. Parker, and R. C. Cooksey
Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E973 - E979.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Chen, P. Raman, P. Bhonagiri, A. B. Strawbridge, G. R. Pattar, and J. S. Elmendorf
Protective Effect of Phosphatidylinositol 4,5-Bisphosphate against Cortical Filamentous Actin Loss and Insulin Resistance Induced by Sustained Exposure of 3T3-L1 Adipocytes to Insulin
J. Biol. Chem., September 17, 2004; 279(38): 39705 - 39709.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Marshall, O. Nadeau, and K. Yamasaki
Dynamic Actions of Glucose and Glucosamine on Hexosamine Biosynthesis in Isolated Adipocytes: DIFFERENTIAL EFFECTS ON GLUCOSAMINE 6-PHOSPHATE, UDP-N-ACETYLGLUCOSAMINE, AND ATP LEVELS
J. Biol. Chem., August 20, 2004; 279(34): 35313 - 35319.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Pang, P. Bounelis, J. C. Chatham, and R. B. Marchase
Hexosamine Pathway Is Responsible for Inhibition by Diabetes of Phenylephrine-Induced Inotropy
Diabetes, April 1, 2004; 53(4): 1074 - 1081.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Obici and L. Rossetti
Minireview: Nutrient Sensing and the Regulation of Insulin Action and Energy Balance
Endocrinology, December 1, 2003; 144(12): 5172 - 5178.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. Haber, T. K. T. Lam, Z. Yu, N. Gupta, T. Goh, E. Bogdanovic, A. Giacca, and I. G. Fantus
N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E744 - E753.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. L. E. Walgren, T. S. Vincent, K. L. Schey, and M. G. Buse
High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E424 - E434.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
L. Shane-McWhorter and P. Geil
Interactions Between Complementary Therapies or Nutrition Supplements and Conventional Medications
Diabetes Spectr, October 1, 2002; 15(4): 262 - 266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Goldberg, C. I. Whiteside, and I. G. Fantus
The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-beta I and -delta
J. Biol. Chem., September 6, 2002; 277(37): 33833 - 33841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Buse, K. A. Robinson, B. A. Marshall, R. C. Hresko, and M. M. Mueckler
Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles
Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E241 - E250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Bifulco, C. Di Carlo, M. Caruso, F. Oriente, A. Di Spiezio Sardo, P. Formisano, F. Beguinot, and C. Nappi
Glucose Regulates Insulin Mitogenic Effect by Modulating SHP-2 Activation and Localization in JAr Cells
J. Biol. Chem., June 28, 2002; 277(27): 24306 - 24314.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Vosseller, L. Wells, M. D. Lane, and G. W. Hart
Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes
PNAS, April 16, 2002; 99(8): 5313 - 5318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. A. Nelson, K. A. Robinson, and M. G. Buse
Insulin Acutely Regulates Munc18-c Subcellular Trafficking. ALTERED RESPONSE IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES
J. Biol. Chem., February 1, 2002; 277(6): 3809 - 3812.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. F. Kralik, P. Liu, B. J. Leffler, and J. S. Elmendorf
Ceramide and Glucosamine Antagonism of Alternate Signaling Pathways Regulating Insulin- and Osmotic Shock-Induced Glucose Transporter 4 Translocation
Endocrinology, January 1, 2002; 143(1): 37 - 46.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakamura, A. J. Barber, D. A. Antonetti, K. F. LaNoue, K. A. Robinson, M. G. Buse, and T. W. Gardner
Excessive Hexosamines Block the Neuroprotective Effect of Insulin and Induce Apoptosis in Retinal Neurons
J. Biol. Chem., November 16, 2001; 276(47): 43748 - 43755.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. E. DeHaven, K. A. Robinson, B. A. Nelson, and M. G. Buse
A Novel Variant of Glutamine: Fructose-6-Phosphate Amidotransferase-1 (GFAT1) mRNA Is Selectively Expressed in Striated Muscle
Diabetes, November 1, 2001; 50(11): 2419 - 2424.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kawanaka, D.-H. Han, J. Gao, L. A. Nolte, and J. O. Holloszy
Development of Glucose-induced Insulin Resistance in Muscle Requires Protein Synthesis
J. Biol. Chem., June 1, 2001; 276(23): 20101 - 20107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. A. Nelson, K. A. Robinson, and M. G. Buse
Defective Akt activation is associated with glucose- but not glucosamine-induced insulin resistance
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E497 - E506.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.